Alexandra Maclean

Chief Executive Officer, AVENUE THERAPEUTICS, INC.

Companies

AVENUE THERAPEUTICS, INC.Board member Jul 3, 2023 to now¹
AVENUE THERAPEUTICS, INC.Chief executive officer Aug 3, 2022 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

AVENUE THERAPEUTICS, INC. ATXI170,000 shares³$73.1K at $0.43Sep 23, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 23, 2024Granted 170,000 shares of AVENUE THERAPEUTICS, INC.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAVENUE THERAPEUTICS, INC., Board member
2
SEC EDGARAVENUE THERAPEUTICS, INC., Chief executive officer
3
SEC EDGARAVENUE THERAPEUTICS, INC. shares after the filing of Sep 23, 2024